Interestingly, the APOE-E2 genotype is associated with worse neurodevelopmental outcomes in CHD, while the APOE-E2 genotype is protective against the late-life neurodegenerative disease Alzheimer’s disease [110, 111]. Here, APOE is linked to Alzheimer disease.